Exor’s Board of Directors approves 2021 results
The Exor Board of Directors’ meeting, chaired by John Elkann, approved today the 2021 Annual Report, which will be submitted for adoption to the Annual General Meeting of Shareholders on 24 May 2022.
The Exor Board of Directors’ meeting, chaired by John Elkann, approved today the 2021 Annual Report, which will be submitted for adoption to the Annual General Meeting of Shareholders on 24 May 2022.
EXOR N.V. (“the Company”) announces today that it will launch a share buyback program (“the Program”). The Company expects that the Program will involve the repurchase from time to time of up to €500mn of ordinary shares by 2024, in line with the disclosure made at the 2021 Investor Day.
Exor N.V. (“Exor” or “the Company”) announces that it has today settled with the Italian Tax Authorities (“Agenzia delle Entrate”) on a complex tax issue, specifically in respect of the Exit Tax.
The Exor Board of Directors’ meeting approved today the 2022 First Half-year Report.
The Exor Board of Directors’ meeting, chaired by John Elkann, approved today the 2021 Annual Report, which will be submitted for adoption to the Annual General Meeting of Shareholders on 24 May 2022.
EXOR N.V. announced today the following Corporate Calendar for 2022:
• 24 March 2022: Board of Directors Meeting for the approval of the Company’s 2021 Annual Report
Paris and Amsterdam, 16 December 2021. Covéa, a leading French mutual insurer and Exor, the leading diversified holding company controlled by the Agnelli family, have signed, following the completion of the required consultation with wor